Ajooni Biotech (India) Today

AJOONI Stock   7.46  0.04  0.54%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Ajooni Biotech is trading at 7.46 as of the 22nd of November 2024, a 0.54 percent increase since the beginning of the trading day. The stock's open price was 7.42. Ajooni Biotech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Ajooni Biotech Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain
Food, Beverage & Tobacco
Category
Consumer Defensive
Classification
Consumer Staples
Ajooni Biotech is entity of India. It is traded as Stock on NSE exchange. The company has 99.37 M outstanding shares. More on Ajooni Biotech Limited

Ajooni Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ajooni Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ajooni Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationPackaged Foods & Meats, Food, Beverage & Tobacco, Consumer Defensive, Consumer Staples, Food Products, Packaged Foods, Consumer Defensive (View all Sectors)
Ajooni Biotech's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ajooni Biotech's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Ajooni Biotech can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ajooni Biotech's financial leverage. It provides some insight into what part of Ajooni Biotech's total assets is financed by creditors.
Liquidity
Ajooni Biotech cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Ajooni Biotech Limited has accumulated 21.68 M in total debt. Debt can assist Ajooni Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Ajooni Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ajooni Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ajooni to invest in growth at high rates of return. When we think about Ajooni Biotech's use of debt, we should always consider it together with cash and equity.

Change In Cash

1.25 Million
Ajooni Biotech Limited (AJOONI) is traded on National Stock Exchange of India in India and employs 109 people. Ajooni Biotech is listed under Packaged Foods & Meats category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 774.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ajooni Biotech's market, we take the total number of its shares issued and multiply it by Ajooni Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ajooni Biotech operates under Food Products sector and is part of Consumer Staples industry. The entity has 99.37 M outstanding shares. Ajooni Biotech generates negative cash flow from operations
Check Ajooni Biotech Probability Of Bankruptcy

Ajooni Biotech Risk Profiles

Although Ajooni Biotech's alpha and beta are two of the key measurements used to evaluate Ajooni Biotech's performance over the market, the standard measures of volatility play an important role as well.

Ajooni Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Ajooni Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Ajooni Biotech Corporate Management

Elected by the shareholders, the Ajooni Biotech's board of directors comprises two types of representatives: Ajooni Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ajooni. The board's role is to monitor Ajooni Biotech's management team and ensure that shareholders' interests are well served. Ajooni Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ajooni Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Swati VijanCompany OfficerProfile
Gursimran SinghCEO DirectorProfile
Partek SinghWholeTime DirectorProfile
Jasjot SinghMD ChairmanProfile

Other Information on Investing in Ajooni Stock

Ajooni Biotech financial ratios help investors to determine whether Ajooni Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajooni with respect to the benefits of owning Ajooni Biotech security.